1. Home
  2. Vol 4, No 1 (2022)
  3. Abimana

A Cross-sectional Study of the Assessment of Venous Thromboembolism Risk and Use of Anticoagulant Thromboprophylaxis

Emile Abimana, Etienne Ntabanganyimana, Raphael Ndahimana, Appolinaire Bizimana, Ernestine Umutesi, R. Osee Sebatunzi, Florence Masaisa

Abstract


Background: Venous thromboembolism (VTE) is a common and preventable disease among non-surgical hospitalized patients. Its incidence is high and alarming. Acute medical patients have VTE risk during and after hospitalization. The Padua prediction score is a risk model created to identify high VTE risk patients among non-surgical hospitalized patients. Methods: We performed a cross-sectional survey of 107 patients admitted to Internal Medicine wards who were assessed as acutely ill patients at Emergency Department, in a period of 4 weeks. The demographic and clinical data were collected using a designed questionnaire. VTE risk was defined as having a Padua Prediction score of ≥4 points. A statistical analysis was done to determine prevalence. The patients at high VTE risk received thromboprophylaxis. Results: One hundred and seven eligible patients were included. 84% were found to be at high risk for VTE. Among physiologically unstable patients, 60% of the patients were classified in red color during the time of triage; this means they were severely sick and needed resuscitation. Among the leading diagnosis, severe pneumonia was predominant (29%). Severe pneumonia and uncontrolled DM showed a significant association with high VTE risk. 11.1% of high VTE risk patients were taking anticoagulant thromboprophylaxis prior to the recruitment. Conclusion:This study demonstrated a high prevalence of VTE risk among acute ill medical patients and underuse of anticoagulants for thromboprophylaxis in potential patients at Kigali University Teaching Hospital, CHUK. The Padua prediction score should be implemented for early detection of patients at-risk of VTE in severely ill patients and to start anticoagulant thromboprophylaxis on time for reducing mortality and morbidity.

 

Doi: 10.28991/SciMedJ-2022-0401-5

Full Text: PDF


Keywords


Venous Thromboembolism Risk; Rwanda; Anticoagulant Thromboprophylaxis; VTE.

References


Alikhan, R., Peters, F., Wilmott, R., & Cohen, A. T. (2004). Fatal pulmonary embolism in hospitalised patients: A necropsy review. Journal of Clinical Pathology, 57(12), 1254–1257. doi:10.1136/jcp.2003.013581.

Stein, P. D., & Henry, J. W. (1995). Prevalence of Acute Pulmonary Embolism among Patients in a General Hospital and at Autopsy. Chest, 108(4), 978–981. doi:10.1378/chest.108.4.978.

Spyropoulos, A. C. (2005). Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest, 128(2), 958–969. doi:10.1378/chest.128.2.958.

Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008). Prevention of Venous Thromboembolism. Chest, 133(6), 381S-453S. doi:10.1378/chest.08-0656.

MacDougall, D. A., Feliu, A. L., Boccuzzi, S. J., & Lin, J. (2006). Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. American Journal of Health-System Pharmacy, 63(20_Supplement_6), S5–S15. doi:10.2146/ajhp060388.

Alikhan, R., Cohen, A. T., Combe, S., Samama, M. M., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Olsson, C.-G., & Turpie, A. G. G. (2004). Risk Factors for Venous Thromboembolism in Hospitalized Patients with Acute Medical Illness. Archives of Internal Medicine, 164(9), 963. doi:10.1001/archinte.164.9.963.

Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012). Prevention of VTE in Nonorthopedic Surgical Patients. Chest, 141(2), e227S-e277S. doi:10.1378/chest.11-2297.

Taher, A. T., Aoun, J., & Salameh, P. (2011). The AVAIL ME study: A multinational survey of VTE risk and prophylaxis. Journal of Thrombosis and Thrombolysis, 31(1), 47–56. doi:10.1007/s11239-010-0492-2.

Barbar, S., Noventa, F., Rossetto, V., Ferrari, A., Brandolin, B., Perlati, M., De Bon, E., Tormene, D., Pagnan, A., & Prandoni, P. (2010). A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. Journal of Thrombosis and Haemostasis, 8(11), 2450–2457. doi:10.1111/j.1538-7836.2010.04044.x.

Decousus, H., Tapson, V. F., Bergmann, J. F., Chong, B. H., Froehlich, J. B., Kakkar, A. K., Merli, G. J., Monreal, M., Nakamura, M., Pavanello, R., Pini, M., Piovella, F., Spencer, F. A., Spyropoulos, A. C., Turpie, A. G. G., Zotz, R. B., FitzGerald, G., & Anderson, F. A. (2011). Factors at admission associated with bleeding risk in medical patients: Findings from the improve investigators. Chest, 139(1), 69–79. doi:10.1378/chest.09-3081.

Uwamahoro, C., Aluisio, A. R., Chu, E., Reibling, E., Mutabazi, Z., Karim, N., Byiringiro, J. C., Levine, A. C., & Guptill, M. (2020). Evaluation of a modified South African Triage Score as a predictor of patient disposition at a tertiary hospital in Rwanda. African Journal of Emergency Medicine, 10(1), 17–22. doi:10.1016/j.afjem.2019.10.001.

Abboushi, N., Yezhelyev, M., Symbas, J., & Nahai, F. (2012). Facelift complications and the risk of venous thromboembolism: A single center’s experience. Aesthetic Surgery Journal, 32(4), 413–420. doi:10.1177/1090820X12442213.

White, R. H. (2003). The Epidemiology of Venous Thromboembolism. Circulation, 107(23_suppl_1). doi:10.1161/01.cir.0000078468.11849.66.

Mugeni, R., Nkusi, E., Rutaganda, E., Musafiri, S., Masaisa, F., Lewis, K. L., Simpao, M., Tugirimana, P. L., & Walker, T. D. (2019). Proximal deep vein thrombosis among hospitalised medical and obstetric patients in Rwandan university teaching hospitals: Prevalence and associated risk factors: A cross-sectional study. BMJ Open, 9(11). doi:10.1136/bmjopen-2019-032604.

Canonico, M. E., Santoro, C., Avvedimento, M., Giugliano, G., Mandoli, G. E., Prastaro, M., ... & Esposito, G. (2022). Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment. Biomolecules, 12(2), 259. doi:10.3390/biom12020259.

Roberts, L. N., Hernandez‐Gea, V., Magnusson, M., Stanworth, S., Thachil, J., Tripodi, A., & Lisman, T. (2022). Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 20(10), 2237-2245. doi:10.1111/jth.15829.


Full Text: PDF

DOI: 10.28991/SciMedJ-2022-0401-5

Refbacks



Copyright (c) 2022 Etienne Ntabanganyimana